| Original language | English (US) |
|---|---|
| Pages (from-to) | 1062 |
| Number of pages | 1 |
| Journal | Pediatric Research |
| Volume | 89 |
| Issue number | 5 |
| DOIs |
|
| State | Published - Apr 2021 |
| Externally published | Yes |
Bibliographical note
Funding Information:NASAʼs work is funded by the NIH/National Institute of Child Health and Human Development (NICHD), award #R01HD089866, and by an award from the NIH Fogarty International Center via the Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA), for the Central and West Africa Implementation Science Alliance (CAWISA).
Funding Information:
In 2010, I joined the Epidemiology and Prevention Division of the Institute of Human Virology, University of Maryland School of Medicine, then led by Dr. William Blattner. However, I have been based full-time in Nigeria as Senior Technical Advisor for Pediatric/Adolescent HIV at the Institute of Human Virology Nigeria, Abuja. My research leverages on implementation science methods to sustainably improve disease prevention and treatment outcomes for children, especially in HIV, malaria, tuberculosis, and now, COVID-19. As a Principal Investigator, my grants include prevention of mother-to-child transmission of HIV and adolescent HIV studies funded by the World Health Organization, the American Academy of Pediatrics, and the NIH. I have concentrated my work in West and Central Africa, which lags behind the rest of Africa in child health indices and research evidence generated. I am an active member of the Nigeria Implementation Science Alliance (NISA), and I lead the Central and West Africa Implementation Science Alliance (CAWISA).